ATM and cancer: The similarity between AtmKD/- cells and ATM kinase inhibitor treated Atm+/-(+) cells further suggest that ATM inhibitors, which have recently entered clinical trials, could potentially increase the efficacy of Topo1 inhibitors in ATM+/+ cancers.